
A study published in Nature Genetics used single-cell spatial transcriptomics to investigate how neoadjuvant chemotherapy and radiotherapy alter the tumor microenvironment (TME) in pancreatic ductal adenocarcinoma. The study team developed a computational tool, spatially constrained optimal transport interaction analysis (SCOTIA), to map ligand-receptor interactions within the tumor and evaluate changes induced by treatment. Their findings suggest that therapy-induced remodeling of the TME involves significant alterations in ligand-receptor interactions, potentially offering insights into overcoming therapeutic resistance. Co-first authors Carina Shiau and Jingyi Cao emphasize that understanding these changes is crucial for improving treatment outcomes.
Like
Save
Share